Gilead Sciences is an American biopharmaceutical company that researches, develops and commercialises drugs. Gilead’s therapeutic areas of focus include HIV/AIDS, liver
diseases, haematology and oncology, inflammatory and respiratory diseases and cardiovascular conditions.
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated